Gianrico Farrugia: Mayo Clinic and GE HealthCare Transform Prostate Cancer Care
Gianrico Farrugia, President and CEO at Mayo Clinic, shared a post on LinkedIn: “Today, Mayo Clinic announced a new theranostics research collaboration with GE HealthCare to support new therapies for…
Read the full articleYou might also wanna read
GE HealthCare and Mayo Clinic launch theranostics study to personalize prostate cancer treatment
CHICAGO, Ill. and ROCHESTER, Minn. — GE HealthCare and Mayo Clinic today announced the MI-BET (Molecular Imaging Biomarker-Based End of Ther
mayocl.in·1d ago
Mayo Clinic aligns Berg Innovation Exchange with Business Development to accelerate healthcare innovation
Mayo Clinic’s Berg Innovation Exchange and Business Development unite expertise in collaboration, commercialization and venture creation to
mayocl.in·9d ago
Natera's Signatera Wins EU Certification for Cancer Recurrence Monitoring
Certification allows Natera to keep offering the cancer-recurrence test across the EU as the bloc phases out its previous device framework.
Mitesh Borad, M.D., an oncologist at Mayo Clinic in Arizona, was part of the research for a new drug proven to give pancreatic cancer patients more time. He speaks on pancreatic cancer, risk factors a
Mitesh Borad, M.D., an oncologist at Mayo Clinic in Arizona, was part of the research for a new drug proven to give pancreatic cancer patien
consent.youtube.com·14d ago
Mitesh Borad, M.D., an oncologist at Mayo Clinic in Arizona, was part of the research for a new drug proven to give pancreatic cancer patients more time. He speaks on pancreatic cancer, risk factors a
Mitesh Borad, M.D., an oncologist at Mayo Clinic in Arizona, was part of the research for a new drug proven to give pancreatic cancer patien
consent.youtube.com·14d agoMitesh Borad, M.D., an oncologist at Mayo Clinic in Arizona, was part of the research for a new drug proven to give pancreatic cancer patients more time. He speaks on pancreatic cancer, risk factors a
Mitesh Borad, M.D., an oncologist at Mayo Clinic in Arizona, was part of the research for a new drug proven to give pancreatic cancer patien
consent.youtube.com·14d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.